LBA22 Neoadjuvant chemotherapy with oxaliplatin and capecitabine versus chemoradiation with capecitabine for locally advanced rectal cancer with uninvolved mesorectal fascia (CONVERT): Initial results of a multicenter randomised, open-label, phase III trial

Authors :: Y-M. Sun
Y-H. Gao
Z-F. Zeng
X-Z. Wang
Y. Cheng
Jian Lei
W. Wang
W-L. Li
Y-Z. Zhuang
Z-G. Wu
X-B. Wan
Z-Z. Pan
Y-F. Li
P-R. Ding
Y-K. Ren
Y-Z Li
D-S. Wan
Z-Q. Wang
Rongxin Zhang
C-K. Yang
Source :: Annals of Oncology. 32:S1296
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Chemotherapy
medicine.medical_specialty
Colorectal cancer
business.industry
medicine.medical_treatment
Locally advanced
Hematology
medicine.disease
Oxaliplatin
Capecitabine
Mesorectal fascia
Oncology
medicine
Radiology
Open label
business
medicine.drug

Tools